The analyzed factors in optimization were type of extracting solvent, extracting solvent volume, dispersing solvent volume, pH and protein precipitation.
Outcome measures were: type of antidepressant, dosage, duration and number of target instructions given by the GP.
The conditions varied were type of hydrated zirconia gel, drying temperature before sulfation, calcination temperature after sulfation.
The treatment factors were type of distillers co-product (W-DDGS vs. B-DDGS) and dietary CP content [15.2 vs. 17.3%; dry matter (DM) basis].
Secondary objectives were: type of genotyping requests (systematic/prospective or specific/retrospective), prevalence of the different genotyping techniques, delays between the genotyping KRAS request and therapy with panitumumab.
Among the investigated variables were: type of FRP rod (material and surface pattern), groove-filling material, bonded length, and groove size.
The factors studied were type of fiber, extraction mode, exposing the fiber directly into the sample (DSPME) or into the headspace over the sample (HSSPME), and extraction temperature.
The outcome measures were type of discharge (treatment dropout vs. therapeutic discharge) and clinical impression of the TC outcome (clinically significant vs. non-significant changes).
These four conditions were implemented within a factorial design in which the main factors were "type of observed behavior" (gaze vs. gaze-away) and "context" (target alone vs. target flanked by a distractor).
Main factors were type of diet (i.e., 100 forage and 900 concentrate versus 600 forage and 400 concentrate) and the addition of BEO (i.e., 0 mg/l versus 1.5 mg/l of BEO).
Various factors that would affect the degree of desalination were studied and these were: type of organic membrane liquid (ML), quantity of ML (i.e. its thickness), presence of emulsifier or mobile carrier (MC) in the ML, concentration of MC in ML, presence of polyelectrolyte (sequestrant) in the receptor phase and presence or absence of magnetic stirring.
